Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Blocklisting Interim Review

1st Oct 2013 11:27

RNS Number : 4003P
Hikma Pharmaceuticals Plc
01 October 2013
 



 

Block Listing Six Monthly Return

 

Information provided on this form must be typed or printed electronically and provided to an RIS.

 

Date: 1 October 2013

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")

&

Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")

&

Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP")

Period of return

From:

1 April 2013

To:

30 September 2013

Balance of unallotted securities under scheme(s) from previous return:

SOP: 1,207,400 ordinary shares of 10 pence

LTIP: 216,619 ordinary shares of 10 pence

MIP: 494,919 ordinary shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

SOP: 0 ordinary shares of 10 pence

LTIP: 0 ordinary shares of 10 pence

MIP: 0 ordinary shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

SOP: 164,100 ordinary shares of 10 pence

LTIP: 0 ordinary shares of 10 pence

MIP: 316,559 ordinary shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

SOP: 1,043,300 ordinary shares of 10 pence

LTIP: 216,619 ordinary shares of 10 pence

MIP: 178,360 ordinary shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

 

 

Stock Option Plan ("SOP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

28/03/2013

-

-

1,207,400

Blocklisting return 01/04/2013

05/04/2013

0

2,000

1,205,400

05/04/2013

0

7,000

1,198,400

05/04/2013

0

2,000

1,196,400

05/04/2013

0

10,500

1,185,900

12/04/2013

0

1,400

1,184,500

29/04/2013

0

1,200

1,183,300

29/04/2013

0

3,600

1,179,700

29/04/2013

0

1,700

1,178,000

29/04/2013

0

1,400

1,176,600

29/04/2013

0

3,400

1,173,200

29/04/2013

0

1,700

1,171,500

29/04/2013

0

2,500

1,169,000

29/04/2013

0

2,500

1,166,500

29/04/2013

0

2,500

1,164,000

02/05/2013

0

2,500

1,161,500

02/05/2013

0

3,500

1,158,000

02/05/2013

0

2,500

1,155,500

02/05/2013

0

2,500

1,153,000

02/05/2013

0

17,500

1,135,500

02/05/2013

0

3,500

1,132,000

02/05/2013

0

10,500

1,121,500

13/05/2013

0

4,000

1,117,500

13/05/2013

0

1,700

1,115,800

13/05/2013

0

8,000

1,107,800

13/05/2013

0

5,000

1,102,800

13/05/2013

0

1,700

1,101,100

31/05/2013

0

3,400

1,097,700

31/05/2013

0

3,400

1,094,300

31/05/2013

0

1,700

1,092,600

13/06/2013

0

10,000

1,082,600

13/06/2013

0

1,700

1,080,900

13/06/2013

0

1,000

1,079,900

21/06/2013

0

3,500

1,076,400

21/06/2013

0

8,500

1,067,900

27/06/2013

0

1,700

1,066,200

04/09/2013

0

22,900

1,043,300

Blocklisting return 01/10/2013

 

Long Term Incentive Plan ("LTIP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

20/03/2013

-

-

216,619

Blocklisting return 01/04/13

01/10/2013

0

0

216,619

Blocklisting return 01/10/13

 

 

Management Incentive Plan ("MIP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

14/03/2013

-

-

494,919

Blocklisting return 01/04/13

09/05/2013

0

316,559

178,360

Blocklisting return 01/10/13

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRZMMGGGMKGFZM

Related Shares:

Hikma Pharmaceuticals
FTSE 100 Latest
Value7,970.87
Change268.79